BRSS Global Brass and Copper Holdings Inc.

ADDING MULTIMEDIA New Study: Before a Doctor Listens to Your Heart, Ask If the Stethoscope is Clean!

There are now two reasons for patients to flinch at the touch of a stethoscope: because it’s cold, of course; and because it’s covered with germs.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170511005681/en/

A new study reveals 80% of stethoscopes are contaminated with bacteria and that copper stethoscopes  ...

A new study reveals 80% of stethoscopes are contaminated with bacteria and that copper stethoscopes reduce bacteria loads by 91%. (Graphic: Business Wire)

A new study1 from medical researchers reveals that 80 percent of the stethoscopes they studied were contaminated by high concentrations of bacteria, so much so that they present as much risk of transferring infectious bacteria as the hands of physicians after a physical exam.

The study, published by American Journal of Infection Control, compared bacteria loads on today’s standard stethoscopes and scopes fabricated with antimicrobial copper alloys that continuously kill 99.9 percent of bacteria. CuVerro® is a leading producer of EPA-registered antimicrobial copper.

Researchers discovered that stethoscopes made with traditional materials on the chest pieces, tubing, and diaphragms expose patients to an average of 127.1 CFUs (colony forming units of bacteria). In contrast, the stethoscopes made with antimicrobial copper exposed patients to an average of only 11.7 CFUs. The copper-alloy devices carried bacteria burdens 91 percent lower than standard scopes.

This difference could be significant in an age where patients and medical professionals are increasingly concerned about the incidence of transmitting bacteria that cause healthcare-associated infections, a problem that results in 99,000 patient deaths each year in US hospitals and leads to annual direct and indirect costs totaling between $96 and $147 billion.2

The study, led by Dr. Michael G. Schmidt, Vice Chairman of Microbiology and Immunology at the Medical University of South Carolina, pointed to evidence that there is only a one-in-ten chance that health professionals routinely disinfect their stethoscopes, making the effects of incorporating copper into the design of stethoscopes even more compelling.

The report noted there isn’t a “consistently applied routine of cleaning and disinfecting stethoscopes between patient encounters” even though they come in frequent contact with the "unsanitized skin of patients and the hands, face, neck and clothing of health care workers.”

“Based on these trial results,” Dr. Schmidt noted, “we can say that adding antimicrobial copper stethoscopes to a healthcare facility’s bundle of infection control measures would likely help to limit the spread of infectious agents. In other studies, antimicrobial copper touch surfaces have been demonstrated to work in concert with existing hygiene procedures to help create safer environments.”

The stethoscope study was conducted variously at the Medical University of South Carolina’s Children’s Hospital, the Department of Emergency Medicine at the University of New Mexico, and North Shore University Hospital in New York.

About CuVerro®

CuVerro is manufactured by GBC Metals, LLC, doing business as Olin Brass, a wholly owned subsidiary of Global Brass and Copper, Inc. which is a subsidiary of Global Brass and Copper Holdings, Inc. (NYSE:BRSS), the leading manufacturer and distributor of copper, copper‐alloy and bactericidal copper sheet, strip, plate, foil, rod, ingot and fabricated components in North America and one of the largest in the world. GBC Metals engages in the melting, casting, rolling, drawing, extruding and stamping of specialized copper and copper alloys finished products from scrap, cathode and other refined metals. (OB‐0034‐1510)

1 American Journal of Infection Control

2 Centers for Disease Control and Prevention

EN
11/05/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Global Brass and Copper Holdings Inc.

Global Brass and Copper, Inc.: Update following announcement of acquis...

Our credit view of Global Brass and Copper reflecting sound operating performance and cash generation relative to debt as well as expected difficulty in expanding margins.

Global Brass and Copper, Inc.: Acquisition by Wieland Group enhances l...

Global Brass’ diverse product and end-market mix, particularly in the US, complements Wieland Group’s large global presence in semi-finished copper and copper alloy products.

 PRESS RELEASE

Global Brass and Copper Holdings, Inc. Reports Fourth Quarter and Full...

Global Brass and Copper Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Results Fourth Quarter Highlights Volume of 131.1 million pounds, a 3% year-over-year increase;Net income increased 18% to $6.6 million and diluted earnings per common share increased 16% to $0.29;Adjusted EBITDA decreased 14% to $25.3 million year-over-year;Adjusted diluted earnings per common share increased 87% to $0.56; andThe Company repurchased 400,000 shares of its stock for a total price of $12.6 million. Full Year Highlights Volume of 564.6 million pounds, an increase of 11% year-over-year;Net incom...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Global Brass and Copper, Inc.: Key rating considerations following CFR...

Our credit view of Global Brass and Copper reflecting sound operating performance and cash generation relative to debt as well as expected difficulty in expanding margins.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch